Manufacturer of Controlled Substances; Notice of Registration; Siegfried (Usa), Llc., 30333 [2013-12116]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 99 / Wednesday, May 22, 2013 / Notices
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Siegfried (Usa), Llc.
Dated: May 14, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–12116 Filed 5–21–13; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
By Notice dated November 19, 2012,
and published in the Federal Register
on November 27, 2012, 77 FR 70825,
Siegfried (USA), LLC., 33 Industrial
Park Road, Pennsville, New Jersey
08070, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Drug
Schedule
TKELLEY on DSK3SPTVN1PROD with NOTICES
Gamma
Hydroxybutyric
Acid
(2010).
Dihydromorphine (9145) ...............
Hydromorphinol (9301) .................
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Oripavine (9330) ...........................
Oxymorphone (9652) ...................
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Siegfried (USA), LLC., to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Siegfried (USA), LLC., to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR
§ 1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
VerDate Mar<15>2010
16:59 May 21, 2013
Jkt 229001
DEPARTMENT OF LABOR
Employee Benefits Security
Administration
Proposed Extension of Information
Collection Requests Submitted for
Public Comment
Employee Benefits Security
Administration, Department of Labor.
ACTION: Notice.
AGENCY:
SUMMARY: The Department of Labor (the
Department), in accordance with the
Paperwork Reduction Act of 1995 (PRA
95) (44 U.S.C. 3506(c)(2)(A)), provides
the general public and Federal agencies
with an opportunity to comment on
proposed and continuing collections of
information. This helps the Department
assess the impact of its information
collection requirements and minimize
the public’s reporting burden. It also
helps the public understand the
Department’s information collection
requirements and provide the requested
data in the desired format. The
Employee Benefits Security
Administration (EBSA) is soliciting
comments on the proposed extension of
the information collection requests
(ICRs) contained in the documents
described below. A copy of the ICRs
may be obtained by contacting the office
listed in the ADDRESSES section of this
notice. ICRs also are available at
reginfo.gov (https://www.reginfo.gov/
public/do/PRAMain).
DATES: Written comments must be
submitted to the office shown in the
ADDRESSES section on or before July 22,
2013.
ADDRESSES: G. Christopher Cosby,
Department of Labor, Employee Benefits
Security Administration, 200
Constitution Avenue NW., Washington,
DC 20210, (202) 693–8410, FAX (202)
693–4745 (these are not toll-free
numbers).
I. Supplementary Information
This notice requests public comment
on the Department’s request for
extension of the Office of Management
and Budget’s (OMB) approval of ICRs
contained in the rules and prohibited
transaction exemptions described
below. The Department is not proposing
any changes to the existing ICRs at this
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
30333
time. An agency may not conduct or
sponsor, and a person is not required to
respond to, an information collection
unless it displays a valid OMB control
number. A summary of the ICRs and the
current burden estimates follows:
Agency: Employee Benefits Security
Administration, Department of Labor.
Title: Notice Requirements of the
Health Care Continuation Coverage
Provisions.
Type of Review: Extension of a
currently approved collection of
information.
OMB Number: 1210–0123.
Affected Public: Individuals or
households; Business or other for-profit;
Not-for-profit institutions.
Respondents: 649,000.
Responses: 15,662,333.
Estimated Total Burden Hours:
503,815.
Estimated Total Burden Cost
(Operating and Maintenance):
$20,217,778.
Description: The continuation
coverage provisions of section 601
through 608 of the Employee Retirement
Income Security Act of 1974 (ERISA)
(and parallel provisions of the Internal
Revenue Code (Code)) generally require
group health plans to offer qualified
beneficiaries the opportunity to elect
continuation coverage following certain
events that would otherwise result in
the loss of coverage. Continuation
coverage is a temporary extension of the
qualified beneficiary’s previous group
health coverage. The right to elect
continuation coverage allows
individuals to maintain group health
coverage under adverse circumstances
and to bridge gaps in health coverage
that otherwise could limit their access
to health care. The Consolidated
Omnibus Budget Reconciliation Act of
1985 (COBRA) provides the Secretary of
Labor (the Secretary) with authority
under section 608 of ERISA to carry out
the continuation coverage provisions.
The Conference Report that
accompanied COBRA divided
interpretive authority over the COBRA
provisions between the Secretary and
the Secretary of the Treasury (the
Treasury) by providing that the
Secretary has the authority to issue
regulations implementing the notice and
disclosure requirements of COBRA,
while the Treasury is authorized to
issue regulations defining the required
continuation coverage. The ICR
contained in these rules was approved
by the Office of Management and
Budget (OMB) under OMB Control
Number 1210–0123, which is currently
scheduled to expire on September 30,
2013.
E:\FR\FM\22MYN1.SGM
22MYN1
]]>Agencies
[Federal Register Volume 78, Number 99 (Wednesday, May 22, 2013)]
[Notices]
[Page 30333]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-12116]
[[Page 30333]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
Siegfried (Usa), Llc.
By Notice dated November 19, 2012, and published in the Federal
Register on November 27, 2012, 77 FR 70825, Siegfried (USA), LLC., 33
Industrial Park Road, Pennsville, New Jersey 08070, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of the following basic classes of controlled
substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)........... I
Dihydromorphine (9145)..................... I
Hydromorphinol (9301)...................... I
Methylphenidate (1724)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
Codeine (9050)............................. II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................ II
Oripavine (9330)........................... II
Oxymorphone (9652)......................... II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Siegfried (USA), LLC., to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Siegfried (USA), LLC., to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance
with 21 CFR Sec. 1301.33, the above named company is granted
registration as a bulk manufacturer of the basic classes of controlled
substances listed.
Dated: May 14, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-12116 Filed 5-21-13; 8:45 am]
BILLING CODE 4410-09-P
